Breaking News

AGC Pharma Chemicals Expands HPAPI Manufacturing in Barcelona

Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through commercial manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

AGC Pharma Chemicals, an innovator in pharmaceutical manufacturing with over 40 years of expertise in Contract Development Manufacturing Operations (CDMO) for small molecule APIs based in Barcelona (Spain) and Japan, is expanding its High Potency Active Pharmaceutical Ingredients (HPAPI) capabilities in Barcelona to address the growing demand for HPAPI. This new facility, backed by a significant investment, is set to redefine API production and set new global standards in pharmaceutical manuf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters